Skip to main content
. 2019 Feb 21;20:61. doi: 10.1186/s12882-019-1248-7

Table 3.

Incidence of hospitalization due to chronic kidney disease in relation to complement C3 quartiles (Q1-Q4)

Quartile 1 Quartile 2 Quartile 3 Quartile 4 P for trend a
C3 range (g/L) <1.3 1.31–1.49 1.50–1.71 >4.05
No. of subjects 1069 1195 1145 1143
Incidence (main diagnosis) b 7 16 26 45
Incidence (per 1000 person-years) 0.33 0.69 1.20 2.09
Model 1 d Reference 2.09 (0.86, 5.07) c 3.63 (1.58, 8.36) 6.46 (2.91, 14.3) <0.001
Model 2 e Reference 1.86 (0.77, 4.53) 3.14 (1.36, 7.24) 5.82 (2.62, 12.9) <0.001
Model 3 f Reference 1.68 (0.69, 4.13) 2.71 (1.15, 6.39) 3.16 (1.36, 7.34) 0.003
Incidence (main or contributing diagnosis) g 20 38 51 77
Incidence (per 1000 person-years) 0.96 1.65 2.35 3.60
Model 1 d Reference 1.74 (1.01, 2.98) 2.50 (1.49, 4.19) 3.89 (2.38, 6.37) <0.001
Model 2 e Reference 1.50 (0.87, 2.58) 2.07 (1.23, 3.48) 3.46 (2.12, 5.66) <0.001
Model 3 f Reference 1.39 (0.81, 2.40) 1.50 (0.88, 2.55) 1.73 (1.02, 2.92) 0.047

aAnalysis by Cox proportional hazards model

bIncidence of hospitalization due to chronic kidney disease (defined as 585–586 according to International Classification of Diseases (ICD) 9, and N18 and N19 according to ICD10; main diagnosis refer to cases at the first position; main or contributing diagnosis refer to cases at one of the first three positions)

cAdjusted hazard ratios (95% confidence interval) (all such values)

dCrude model

eAdjusted for age and sex

fAdjusted for age, sex, waist circumference, smoking and drinking habits, low-density lipoprotein cholesterol, diabetes, cardiovascular disease, anti-hypertensive drug medication, and baseline estimated glomerular filtration rate